RichFakirNSE · BSEOpen live analysis →

Himalaya Nutravedics India Ltd

544943.BO · Healthcare

Incorporated in June 2022, Himalaya Nutravedics India Limited is engaged in the manufacturing, marketing, and distribution of Ayurvedic and nutraceutical formulations.

Our view
Avoid
Quality score
66
Discount to fair value
-109%
See the full interactive analysis — quality radar, 12-year financials & more →
Fair value / share
₹58
Discount to fair value
-109%
Quality score
66/100
Return on equity
31.3%
Revenue growth (5y)
141.6%
P/E
14.4

Questions & answers

Is Himalaya Nutravedics India Ltd (544943.BO) a good business?

RichFakir rates Himalaya Nutravedics India Ltd's business quality as decent — 66/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation).

Is Himalaya Nutravedics India Ltd overvalued or undervalued?

On our model, Himalaya Nutravedics India Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.

What is RichFakir's verdict on Himalaya Nutravedics India Ltd (544943.BO)?

RichFakir's educational verdict on Himalaya Nutravedics India Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.

What is Himalaya Nutravedics India Ltd's fair value?

RichFakir's educational estimate of Himalaya Nutravedics India Ltd's fair value is about ₹58 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.

View the full live analysis →

Other companies

GANESHBEROSSARIVADILALINDKUSUMGARMRF522122.BOSANSERAAUGMONTUNIPARTSPETRONETDATAMATICS544670.BO
RichFakir is an educational research tool, not investment advice. Figures are estimates from public filings and may contain errors. Do your own research.